Sarman Singh

About

Professor Sarman Singh has taught Clinical Microbiology & Molecular Medicine at the All India Institute of Medical Sciences, New Delhi, for the last 32 years, after which he was posted as the Director and CEO All India Institute of Medical Sciences, Bhopal, from June 2018 to November 2021. He worked as Director Medical Research and Institutional Collaborations at AVMC, Pondicherry, and is currently working as Founder & Director at Advanced Centre for Chronic and Rare Diseases (ACCORD-asha), New Delhi. He is a well-known researcher, inventor, publisher, and author of more than 390 original articles and research reviews in various peer-reviewed journals, with an H-index of 67 and i10 index of more than 250. He has been listed in the top 2% of Microbiologists of the world consecutively for the last 5 years. He is Editor-in-Chief of the Journal of Laboratory Physicians, Section Editor of PLoS-Neglected Tropical Diseases, and Academic Editor of PLOS One, Medicine, and Tuberculosis Research and Treatment (Hindawi). Reviewer for more than 60 International peer-reviewed journals and an International Grant Reviewer.

Employment

• Advanced Centre for Chronic and Rare Diseases Founder & Director
  2025 - Present
• Aarupadai Veedu Medical College & Hospital Director Medical Research
  2024 - 2025
• Indian Institute of Science Education and Research Bhopal Professor and Mentor
  2021 - 2024
• All India Institute of Medical Sciences Director & CEO
  2018 - 2021
• All India Institute of Medical Sciences Head of the Division
  1989 - 2018
• All India Institute of Medical Sciences Senior Resident
  1988 - 1989

Education

• University of Michigan PG Certificate Course in Epidemiology of Infectious Diseases
  1990 - 1990
• Post Graduate Institute of Medical Education and Research MD
  1985 - 1987
• King George's Medical University MBBS (Bachelor of Medicine & Bachelor of Surgery)
  1977 - 1982

Projects & Funding

Projects & funding information is unavailable.

Publications (586)

• Mapping of Lipidome Profile in Drug-Resistant Clinical Isolates of Mycobacterium tuberculosis Through Quali-Quantitative Liquid Chromatography-Mass Spectrometry Identifies Signature Lipids
  Life 2026 DOI: 10.3390/life16060953
  +Save
• Are microsporidia infections really increasing in HIV/AIDS patients or is it increased awareness?
  International Health 2026 DOI: 10.1093/inthealth/ihag019
  +Save
• Cervico-uterine cancer in India: A persistent concern for the medical fraternity, policymakers, and society
  Journal of Laboratory Physicians 2026 DOI: 10.25259/jlp_387_2025
  +Save
• Harnessing antigenic proteins of Toxoplasma gondii for efficient diagnosis: a study of promising candidates
  Journal of Parasitic Diseases 2025 DOI: 10.1007/s12639-025-01863-7
  +Save
• An Ideal Point-of-Care Test for Screening Tuberculosis Infection
  The Journal of Infectious Diseases 2025 DOI: 10.1093/infdis/jiaf259
  +Save
• Proteomic Analysis and Sequential Events During the in-vivo Acquisition of Drug Resistance in Clinical Isolates of Mycobacterium tuberculosis
  Infectious Disorders - Drug Targets 2025 DOI: 10.2174/0118715265356091250519032548
  +Save
• Publication-equivalence: Conceptually sound but practically challenging
  The Indian Journal of Medical Research 2025 DOI: 10.25259/ijmr_2441_2025
  +Save
• Biomarkers in health and diseases
  Journal of Laboratory Physicians 2025 DOI: 10.25259/jlp_282_2025
  +Save
• Computational identification of dual COX-1 and NIK inhibitors from marine microalga Chlorella vulgaris
  Journal of Genetic Engineering and Biotechnology 2025 DOI: 10.1016/j.jgeb.2025.100531
  +Save
• Diagnostic yield of Xpert MTB/RIF, Xpert MTB/RIF Ultra, and Truenat MTB assays on non-pulmonary samples from suspected cases of extra-pulmonary tuberculosis (EPTB)
  European Journal of Clinical Microbiology & Infectious Diseases 2025 DOI: 10.1007/s10096-025-05177-7
  +Save